MedPath
HSA Approval

FLUOROURACIL INJECTION 50 mg/ml

SIN09904P

FLUOROURACIL INJECTION 50 mg/ml

FLUOROURACIL INJECTION 50 mg/ml

July 23, 1998

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

L01BC02

fluorouracil

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PHARMACHEMIE BV

Active Ingredients

5-FLUOROURACIL

50 mg/ml

Fluorouracil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FLUOROURACIL INJECTION 50 mg/ml - HSA Approval | MedPath